These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Living related donor kidney transplantation in patients with a positive flow cytometry crossmatch. Hong JH; Sadeghian M; Sumrani N; Distant DA; Sommer BG; Norin AJ Transplant Proc; 1996 Jun; 28(3):1614-5. PubMed ID: 8658808 [No Abstract] [Full Text] [Related]
43. Role of HLA matching in cadaveric renal transplantation--influence of improved serologic HLA-DR typing. Leivestad T; Sødal G; Bratlie A; Albrechtsen D; Fauchald P; Pfeffer P; Vartdal F; Thorsby E Transplant Proc; 1993 Feb; 25(1 Pt 1):220-1. PubMed ID: 8438277 [No Abstract] [Full Text] [Related]
44. Comparison of OKT3 and antithymocyte globulin as induction immunosuppressive agents in renal transplantation. Kitabayashi K; Munn SR; Sterioff S Transplant Proc; 1996 Jun; 28(3):1973-5. PubMed ID: 8658964 [No Abstract] [Full Text] [Related]
46. The role of IgA anti-HLA class I antibodies in kidney transplant survival. Koka P; Chia D; Terasaki PI; Chan H; Chia J; Ozawa M; Lim E Transplantation; 1993 Jul; 56(1):207-11. PubMed ID: 8333044 [TBL] [Abstract][Full Text] [Related]
47. Organ shortage and a long waiting list allow local kidney allocation to insure both short ischemia time and good HLA-A, B, DR matching. Mosca F; Bertoni E; Tosi P; Bandini S; Rosati A; Pradella F; Mattiuz P; Taddei G; Nicita G; Rindi P Transplant Proc; 1995 Oct; 27(5):2695-6. PubMed ID: 7482878 [No Abstract] [Full Text] [Related]
48. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression. Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909 [No Abstract] [Full Text] [Related]
49. Importance of HLA matching in highly sensitised renal transplant recipients with high transplant survival rates. The Manchester Kidney Transplant Team. Martin S; Connolly J; Jos V Transplant Proc; 1993 Feb; 25(1 Pt 1):265-6. PubMed ID: 8438295 [No Abstract] [Full Text] [Related]
50. The impact of race and HLA matching on long-term survival following cardiac transplantation. Park MH; Tolman DE; Kimball PM Transplant Proc; 1997; 29(1-2):1460-3. PubMed ID: 9123381 [No Abstract] [Full Text] [Related]
51. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results. Schulz T; Kapischke M; Busing M Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475 [TBL] [Abstract][Full Text] [Related]
52. Dissection of the respective importance of HLA-A,B,DR matching in 3,789 prospective kidney transplants. Hors J; Busson M; Bouteiller AM; Raffoux C; Betuel H; Fauchet R; Tongio MM; Mercier P; Lepetit JC; Dausset J Transplant Proc; 1987 Feb; 19(1 Pt 1):687-8. PubMed ID: 3274842 [No Abstract] [Full Text] [Related]
53. Antibodies against MICA antigens and kidney-transplant rejection. Zou Y; Stastny P; Süsal C; Döhler B; Opelz G N Engl J Med; 2007 Sep; 357(13):1293-300. PubMed ID: 17898098 [TBL] [Abstract][Full Text] [Related]
54. Impact of HLA matching, type of crossmatch, and immunosuppressive therapy on primary pediatric cadaver renal allograft survival. Kerman RH; Sullivan EK; Tejani A Transplant Proc; 1995 Feb; 27(1):656-7. PubMed ID: 7879133 [No Abstract] [Full Text] [Related]
55. Cadaveric kidneys should be allocated according to the HLA match. Opelz G; Wujciak T Transplant Proc; 1995 Feb; 27(1):93-9. PubMed ID: 7879235 [No Abstract] [Full Text] [Related]
56. Low incidence of rejection after synchronous pancreas-kidney transplantation with Neoral. Cattral MS; Hemming AW; Greig PD; Rowsell C; Chari R; Wright E; Donat D; Cole E; Levy GA Transplant Proc; 1998 Aug; 30(5):1946. PubMed ID: 9723346 [No Abstract] [Full Text] [Related]